We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Momentum

News List

Aruvant partners with Lonza to manufacture sickle cell disease treatment pharmaceutical-technology
January 20, 2021
Clinical-stage biopharmaceutical firm Aruvant Sciences and Lonza have entered a strategic long-term manufacturing agreement for the former’s one-time investigational gene therapy for sickle cell disease (SCD), ARU-1801.
Asia HealthTech momentum continues unabated closing H1 2019 at $2.5B biospectrumasia
July 09, 2019
Galen Growth Asia shared 2019 Half Year Asia Healthtech Landscape report, the bi-annual go-to-reference for key trends and insights for investors, enterprises and start-ups
Asia HealthTech momentum continues unabated closing H1 2019 at US$2.5B biospectrumasia
July 08, 2019
Galen Growth Asia shared 2019 Half Year Asia Healthtech Landscape report, the bi-annual go-to-reference for key trends and insights for investors, enterprises and start-ups
Manufacturing hiccup in China trips up Sanofi's vaccine sales momentum fiercevaccines
May 17, 2018
After a strong 2017, Sanofi Pasteur got off to a less-than-stellar start this year. In China, inspectors put a temporary kibosh on imports of the pediatric shot Pentaxim,